PATENT CLAIM ANALYSIS

Application Number: 16375404
Application Type: Utility
Filing Date: 2019-04
Publication Date: 2019-07
Patent Classification: ["424", "400000"]

Abstract:
The present invention relates to a pharmaceutical composition for treating, preventing or improving premature ejaculation, which is taken on demand prior to sexual activity, the composition comprising clomipramine hydrochloride in an amount of 14 to 16 mg, preferably about 15 mg, as an active ingredient. More preferably, the composition of the present invention further comprises pregelatinized starch and sodium starch glycolate. The pharmaceutical composition of the present invention can provide rapid onset of efficacy, reduce a dissolution (absorption) deviation according to the patient's gastrointestinal pH conditions and minimize side effects.

Claim (Index 11):
A pharmaceutical composition for oral administration configured to treat, prevent or improve premature ejaculation, the composition being taken on demand prior to sexual activity, wherein the composition comprises clomipramine hydrochloride in an amount of 14 to 16 mg as an active ingredient.

Metadata:
- Claim Count in Document: 44.0
- Percentile: 100.0
- Lexical Diversity: 1.47143
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['09996407', '14463966', '10806072', '14463921', '14463959']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7490363551310715
- 35 USC 102 Novelty (BERT): 0.5013504042528734
- Combined Prediction Score: 0.7242677600432518
- Mean Citation Score: 197.894538
- Max Citation Score: 199.72098
- Similarity Product: 123.51168750514267

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test